Supraaortic arteries: Contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography - Feasibility study

Radiology

Volumn 249, Issue 3, 2008, Pages 980-990

  Tomasian, Anderanik ^a   Salamon, Noriko ^a   Lohan, Derekg ^a   Jalili, Mehdi ^a   Villablanca, J Pablo ^a   Finn, J Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; AORTA; ARTERY OCCLUSION; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; CAROTID ARTERY DISEASE; COMPARATIVE STUDY; FIBROMUSCULAR DYSPLASIA; HEADACHE; INTRACRANIAL ANEURYSM; METHODOLOGY; MIDDLE AGED; MOYAMOYA DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; STROKE; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; VERTEBROBASILAR INSUFFICIENCY; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; AMAUROSIS FUGAX; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY DISEASES; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; FIBROMUSCULAR DYSPLASIA; HEADACHE; HUMANS; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MOYAMOYA DISEASE; STROKE; VERTEBROBASILAR INSUFFICIENCY; VERTIGO;

EID: 58149201472     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2493080209     Document Type: Article

References (38)

1. Hankey GJ, Warlow CP, Sellar RJ. Cerebral angiographic risk in mild cerebrovascular disease. Stroke 1990;21:209-222.
2. Heiserman JE, Dean BL, Hodak JA, et al. Neurologic complications of cerebral angiography. AJNR Am J Neuroradiol 1994;15:1401-1407.
3. American College of Radiology. The ACR practice guideline for the performance of diagnostic cervicocerebral angiography in adults. Reston, Va: American College of Radiology, 2005;57-70.
4. Marcus CD, Ladam-Marcus VJ, Bigot JL, Clement C, Baehrel B, Menanteau BP. Carotid arterial stenosis: evaluation at CT angiography with the volume-rendering technique. Radiology 1999;211:775-780.
5. Berg M, Zhang Z, Ikonen A, et al. Multi-detector row CT angiography in the assessment of carotid artery disease in symptomatic patients: comparison with rotational angiography and digital subtraction angiography. AJNR Am J Neuroradiol 2005;26:1022-1034.
6. Randoux B, Marro B, Koskas F, et al. Carotid artery stenosis: prospective comparison of CT, three-dimensional gadolinium-enhanced MR, and conventional angiography. Radiology 2001;220:179-185.
7. Josephson SA, Bryant SO, Mak HK, Johnston SC, Dillon WP, Smith WS. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology 2004;63:457-460.
8. Remonda L, Senn P, Barth A, Arnold M, Lovblad KO, Schroth G. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. AJNR Am J Neuroradiol 2002;23:213-219.
9. Carr JC, Ma J, Desphande V, Pereles S, Laub G, Finn JP. High-resolution breath-hold contrast-enhanced MR angiography of the entire carotid circulation. AJR Am J Roentgenol 2002;178:543-549.
10. Randoux B, Marro B, Koskas F, Chiras J, Dormont D, Marsault C. Proximal great vessels of aortic arch: comparison of three-dimensional gadolinium-enhanced MR angiography and digital subtraction angiography. Radiology 2003;229:697-702.
11. Nael K, Villablanca JP, McNamara TO, Laub G, Finn JP. Supraaortic arteries: contrast-enhanced MR angiography at 3.0 T - highly accelerated parallel acquisition for improved spatial resolution over an extended field of view. Radiology 2007;242:600-609.
12. Nael K, Ruehm SG, Michaely HJ, et al. High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla. Invest Radiol 2006;41:391-399.
13. Sodickson DK, McKenzie CA, Li W, Wolff S, Manning WJ, Edelman RR. Contrast-enhanced 3D MR angiography with simultaneous acquisition of spatial harmonics: a pilot study. Radiology 2000;217:284-289.
14. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
15. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Re-son Med 2002;47:1202-1210.
16. Pruessmann KP. Parallel imaging at high field strength: synergies and joint potential. Top Magn Reson Imaging 2004;15:237-244.
17. Unterweger M, Froehlich JM, Kubik-Huch RA, et al. Dose optimization of contrast-enhanced carotid MR angiography. Eur Radiol 2005;15:1797-1805.
18. Jourdan C, Heverhagen JT, Knopp MV. Dose comparison of single-vs. double-dose in contrast-enhanced magnetic resonance angiography of the carotid arteries: intraindividual cross-over blinded trial using Gd-DTPA. J Magn Reson Imaging 2007;25:557-563.
19. Hedley AJ, Molan MP, Hare DL, Anavekar NS, Ierno FL. Nephrogenic systemic fibrosis associated with gadolinium-containing contrast media administration in patients with reduced glomerular filtration rate. Nephrology (Carlton) 2007;12:111.
20. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
21. Perazella MA, Rodby RA. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease. Am J Med 2007;120:561-562.
22. Thomsen HS, Morcos SK. Nephrogenic systemic fibrosis and nonionic linear chelates. AJR Am J Roentgenol 2007;188:W580.
23. Campeau NG, Huston J III, Bernstein MA, Lin C, Gibbs GF. Magnetic resonance angiography at 3.0 Tesla: initial clinical experience. Top Magn Reson Imaging 2001;12:183-204.
24. Willinek WA, Born M, Simon B, et al. Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging - initial experience. Radiology 2003;229:913-920.
25. Rinck PA, Muller RN. Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents. Eur Radiol 1999;9:998-1004.
26. Kanal E, Broome DR, Martin DR, Thomsen HS. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology 2008;246:11-14.
27. Marckmann P, Skov L, Rossen K, Heaf JG, Thomsen HS. Case-control study of gadodi-amide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 2007;22:3174-3178.
28. Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007;245:168-175.
29. Swaminathan S, Shah SV. New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol 2007;18:2636-2643.
30. Leclerc X, Nicol L, Gauvrit JY, et al. Contrast-enhanced MR angiography of supraaortic vessels: the effect of voxel size on image quality. AJNR Am J Neuroradiol 2000;21:1021-1027.
31. Nael K, Michaely HJ, Villablanca P, Salamon N, Laub G, Finn JP. Time-resolved contrast enhanced magnetic resonance angiography of the head and neck at 3.0 Tesla: initial results. Invest Radiol 2006;41:116-124.
32. Weiger M, Pruessmann KP, Leussler C, Roschmann P, Boesiger P. Specific coil design for SENSE: a six-element cardiac array. Magn Reson Med 2001;45:495-504.
33. de Zwart JA, Ledden PJ, van Gelderen P, Bodurka J, Chu R, Duyn JH. Signal-to-noise ratio and parallel imaging performance of a 16-channel receive-only brain coil array at 3.0 Tesla. Magn Reson Med 2004;51:22-26.
34. Fink C, Puderbach M, Ley S, et al. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels. Invest Radiol 2004;39:143-148.
35. Nael K, Fenchel M, Krishnam M, Finn JP, Laub G, Ruehm SG. 3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent. Invest Radiol 2007;42:392-398.
36. Willinek WA, Gieseke J, von Falkenhausen M, et al. Sensitivity encoding (SENSE) for high spatial resolution time-of-flight MR angiography of the intracranial arteries at 3.0 tesla. Rofo 2004;176:21-26.
37. Haacke EM, Brown RW, Thompson MR, Venkatesan R, eds. Signal, contrast, and noise. In: Duerk JL, Wehrli FW, eds. Magnetic resonance imaging: physical principles and sequence design. New York, NY: Wiley, 1999;349-352.
38. Krause U, Kroencke T, Spielhaupter E, et al. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection. J Magn Re-son Imaging 2005;21:449-454.